Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
|
362-06-001.
Characterizing the relationship between cerebral perfusion and amyloid PET Centiloids in Alzheimer’s disease
Impact: Our finding of lower arterial spin labeling (ASL) cerebral blood flow (CBF) in key AD-related regions correlating with higher global amyloid-beta (Aβ) PET in Centiloids suggests that Aβ accumulation is one of the factors contributing to reduced CBF in AD.
|
||
|
362-06-002.
Older Age and Heart Disease are Associated with a Faster Increase in ARTS, an In-Vivo Marker of Cerebral Arteriolosclerosis
Impact: This longitudinal study of ARTS enhances our understanding of the factors that are associated with a different rate of change in this marker, and identifies older age and heart disease as factors that may be linked to faster arteriolar deterioration.
|
||
|
362-06-003.
Aging Effects on Nigrostriatal Structure, Hemodynamics, and Connectivity: Implications for Parkinson’s Disease
Impact: These findings reveal early
nigrostriatal vulnerability with aging and provide a sensitive framework for
detecting preclinical neural changes that may predispose the aging brain to
Parkinsonian degeneration.
|
||
|
362-06-004.
Microstructural Characterization of Hippocampal Subfields in Midlife APOE e4-Carriers using Soma and Neurite Density Imaging
Impact: Healthy midlife APOE ε4-carriers showed reduced cell-body signal fractions in the right anterior CA2/CA3 hippocampus, indicating localised microstructural vulnerability associated with Alzheimer’s disease genetic risk. SANDI has potential to detect subtle cellular alterations linked to early pathophysiology.
|
||
|
362-06-005.
A Connectome Analysis Linking Brain Structure and Pathophysiological Measures Toward Early Alzheimer’s Detection
Impact: This expanded connectome analysis integrates brain and pathophysiological measures to map intra- and cross-modality relationships relevant in early stages of AD. The resulting maps highlight multimodal connectivity patterns that may enhance our understanding of the relationships between preclinical neurodegenerative processes.
|
||
|
362-06-006.
Quantifying Axonal Microstructural Changes in Aging Using Ultra-High Gradient Diffusion MRI
Impact: Ultra-high gradient diffusion MRI enables robust estimation of axonal integrity in the aging brain, promising to facilitate earlier detection of age-related changes before macrostructural changes and symptoms of neurodegeneration are evident.
|
||
|
362-06-007.
Impact of childhood adversity on age-related changes of brain metabolites and tissue parameters using 1H MRS and MPM at 3T
Impact: Gaining insight into mid- to long-term effects
of early-life stress (ELS) on the adult human brain at a metabolic and
microstructural level can guide personalized treatment approaches to counteract
potential pathologies, such as neuroinflammation, neurodegeneration or
accelerated cognitive decline.
|
||
|
362-06-008.
Regional cerebral blood flow changes at specific time-point during amyloid-targeted therapy for Alzheimer's disease patients
Impact: It highlights the use of pseudo continuous - arterial spin labelling (pcASL) MRI as an imaging biomarker for amyloid-targeted therapy monitoring
|
||
|
362-06-009.
GABA+, Glx and Glutathione vary by age, sex and brain region in a sample of healthy adults
Impact: Without appropriate normative data,
imaging research in clinical populations is not meaningful. This study
generated MRS data from difficult to resolve metabolites in a cohort of healthy
adults. Data from this investigation provides important reference information
for clinical comparisons.
|
||
|
362-06-010.
Progressive Disruptions in Glymphatic Function and Dynamic Functional Connectivity Across the Alzheimer's Disease Spectrum
Impact: This study reveals that glymphatic
dysfunction, evident from the SCD stage, leads to cognitive decline in
Alzheimer's disease by disrupting dynamic network function, thus identifying
key biomarkers and therapeutic targets for early intervention.
|
||
|
362-06-011.
The TREM2 R62H variant relates to differences in brain structure across the Alzheimer’s disease continuum
Impact: This is the first investigation of the impact of the TREM2 R62H variant on cognitively normal carriers. Our findings point to early brain changes that may point to mechanistic contributors to Alzheimer's disease.
|
||
|
362-06-012.
Revealing gray and white matter microstructure differences in subjective cognitive decline using NODDI
Impact: This study uses NODDI to find GM/WM microstructural changes in SCD, for identifying key predictors and further building a high-performance joint model. It may aid early AD detection and offer an objective imaging tool for SCD diagnosis.
|
||
|
362-06-013.
Sub-voxel quantitative susceptibility mapping of hippocampal subfields in Alzheimer’s disease and mild cognitive impairment
Impact: The current findings allow us to distinguish the
opposite susceptibility changes of hippocampal subfields and deepen our understanding of the pathology of the hippocampus in Alzheimer's disease
(AD) and mild cognitive impairment (MCI).
|
||
|
362-06-014.
Ventricular Enlargement is the Key Driver of Caudate Displacement in Aging and Vascular Pathologies
Impact: Early signs of vascular stress appear in small periventricular areas like the caudate and nearby white matter. Ratios such as FH/IT, FH/CC, and CC/IT reveal these changes, allowing accurate identification of subcortical remodeling and vascular alterations linked to aging.
|
||
|
362-06-015.
CSF flow dynamics throughout the ventricular system in preclinical Alzheimer’s disease using 4D flow MRI
Impact: 4D flow MRI showed regional differences
in CSF flow dynamics between amyloid-beta (Aβ) positive (N=42) and negative (N=89) cognitively
unimpaired individuals, suggesting that altered CSF flow dynamics could be
implicated in preclinical Alzheimer’s disease, potentially reflecting impaired
CSF-mediated waste clearance.
|
||
|
362-06-016.
Quantitative Assessment of CSF-Vascular Coupling in Alzheimer’s Disease Using Phase-Contrast and 4D-Flow MRI
Impact: PC-MRI and 4D-Flow reveal altered CSF-vascular coupling in Alzheimer’s disease, reflecting glymphatic impairment and offering a non-invasive, quantitative method for early diagnosis and disease monitoring.
|
© 2026 International Society for Magnetic Resonance in Medicine